Literature DB >> 21467296

All stressed out without ATM kinase.

J Jefferson P Perry1, John A Tainer.   

Abstract

Ataxia-telangiectasia (A-T) is a rare, neurodegenerative, inherited disease arising from mutations in the kinase A-T mutated (ATM), which promotes cell cycle checkpoints and DNA double-strand break repair. Puzzlingly, these ATM activities fail to fully explain A-T neuropathologies, which instead have links to stress induced by reactive oxygen species (ROS). However, a landmark discovery reveals an unexpected intersection of ROS and kinase signaling: ATM can be directly activated by oxidation to form a disulfide-linked dimer in a mechanism distinct from DNA damage activation. When combined with notable structural-based insights into the ATM homolog DNA-PK (DNA-protein kinase) and mTOR (mammalian target of rapamycin), these results suggest conformation and assembly mechanisms to signal oxidative stress through an ATM nodal point. These findings fundamentally affect our understanding of ROS and ATM signaling and of the A-T phenotype, with implications for altering signaling in cancer cells to increase sensitivities to current therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467296      PMCID: PMC3308628          DOI: 10.1126/scisignal.2001961

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  38 in total

1.  Redox regulation of Cdc25C.

Authors:  Pavel A Savitsky; Toren Finkel
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

Review 2.  Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediate cellular radiosensitivity.

Authors:  L Chessa; P Petrinelli; A Antonelli; M Fiorilli; R Elli; L Marcucci; A Federico; E Gandini
Journal:  Am J Med Genet       Date:  1992-03-01

3.  Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid.

Authors:  M Gatei; D Shkedy; K K Khanna; T Uziel; Y Shiloh; T K Pandita; M F Lavin; G Rotman
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

4.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species.

Authors:  K Savitsky; S Sfez; D A Tagle; Y Ziv; A Sartiel; F S Collins; Y Shiloh; G Rotman
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

5.  Radiosensitivity in ataxia-telangiectasia: a new explanation.

Authors:  R B Painter; B R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Ataxia-telangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain.

Authors:  M Toyoshima; T Hara; H Zhang; T Yamamoto; S Akaboshi; E Nanba; K Ohno; N Hori; K Sato; K Takeshita
Journal:  Am J Med Genet       Date:  1998-01-13

7.  Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice.

Authors:  Nora Stern; Ayala Hochman; Naty Zemach; Nir Weizman; Ilan Hammel; Yosef Shiloh; Galit Rotman; Ari Barzilai
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

8.  Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells.

Authors:  Keisuke Ito; Atsushi Hirao; Fumio Arai; Sahoko Matsuoka; Keiyo Takubo; Isao Hamaguchi; Kana Nomiyama; Kentaro Hosokawa; Kazuhiro Sakurada; Naomi Nakagata; Yasuo Ikeda; Tak W Mak; Toshio Suda
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

9.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

Review 10.  ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage.

Authors:  Ari Barzilai; Galit Rotman; Yosef Shiloh
Journal:  DNA Repair (Amst)       Date:  2002-01-22
View more
  8 in total

Review 1.  Signal transduction by mitochondrial oxidants.

Authors:  Toren Finkel
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  The dark side of the oxidative force in angiogenesis.

Authors:  Bethany A Kerr; Tatiana V Byzova
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

3.  Glutamine deprivation induces interleukin-8 expression in ataxia telangiectasia fibroblasts.

Authors:  Min-Hyun Kim; Aryung Kim; Ji Hoon Yu; Joo Weon Lim; Hyeyoung Kim
Journal:  Inflamm Res       Date:  2014-01-12       Impact factor: 4.575

Review 4.  Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.

Authors:  Cornelia M Weyand; Yi Shen; Jorg J Goronzy
Journal:  Free Radic Biol Med       Date:  2018-03-07       Impact factor: 7.376

Review 5.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

6.  Proteomic profiling of ATM kinase proficient and deficient cell lines upon blockage of proteasome activity.

Authors:  Valeria Marzano; Simonetta Santini; Claudia Rossi; Mirco Zucchelli; Annamaria D'Alessandro; Carlo Marchetti; Michele Mingardi; Venturina Stagni; Daniela Barilà; Andrea Urbani
Journal:  J Proteomics       Date:  2012-05-26       Impact factor: 4.044

7.  Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells.

Authors:  Jill E Hesse; Liwen Liu; Cynthia L Innes; Yuxia Cui; Stela S Palii; Richard S Paules
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 8.  Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Begoña Martin-Castillo; Jorge Joven; Luciano Vellon; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-11       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.